logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Duncan, Kimbell Rush
    Director born in April 1965
    Individual (7 offsprings)
    Officer
    icon of calendar 2020-08-21 ~ now
    OF - Director → CIF 0
  • 2
    Huston, Richard John
    Investor born in September 1961
    Individual (10 offsprings)
    Officer
    icon of calendar 2021-09-06 ~ now
    OF - Director → CIF 0
  • 3
    LDW IMMUNOLOGY LIMITED - 2005-02-14
    BEALAW (688) LIMITED - 2004-02-13
    icon of addressThe Walbrook Building, 25 Walbrook, London, England
    Active Corporate (5 parents, 6 offsprings)
    Equity (Company account)
    1,293,480 GBP2024-12-31
    Person with significant control
    icon of calendar 2016-04-21 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 9
  • 1
    Buckley, Brendan, Professor
    Director born in May 1950
    Individual (2 offsprings)
    Officer
    icon of calendar 2020-04-16 ~ 2025-06-05
    OF - Director → CIF 0
  • 2
    Yeatman, Graham Edward
    Director born in May 1966
    Individual (4 offsprings)
    Officer
    icon of calendar 2016-04-21 ~ 2018-12-31
    OF - Director → CIF 0
  • 3
    Stoloff, Gregory Alan
    Director born in December 1961
    Individual (11 offsprings)
    Officer
    icon of calendar 2016-04-14 ~ 2021-09-06
    OF - Director → CIF 0
  • 4
    Friel, Cathal
    Director born in November 1964
    Individual (9 offsprings)
    Officer
    icon of calendar 2020-04-16 ~ 2025-06-06
    OF - Director → CIF 0
  • 5
    Phillips, Trevor Michael
    Director born in May 1961
    Individual (7 offsprings)
    Officer
    icon of calendar 2018-04-27 ~ 2020-04-16
    OF - Director → CIF 0
  • 6
    Sharpington, Tim
    Director born in March 1966
    Individual (3 offsprings)
    Officer
    icon of calendar 2018-12-24 ~ 2020-04-16
    OF - Director → CIF 0
  • 7
    Denny, Kym
    Director born in December 1967
    Individual
    Officer
    icon of calendar 2016-04-21 ~ 2018-04-27
    OF - Director → CIF 0
  • 8
    Bannister, Robin
    Director born in March 1961
    Individual (4 offsprings)
    Officer
    icon of calendar 2016-04-14 ~ 2020-08-21
    OF - Director → CIF 0
  • 9
    icon of addressQueen Mary Bioenterprises Innovation Centre, 42 New Road, London, England
    Corporate (3 offsprings)
    Person with significant control
    2016-04-21 ~ 2025-04-02
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

IMUTEX LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Called-up share capital (not paid)
0 GBP2024-12-31
0 GBP2023-12-31
Intangible Assets
0 GBP2024-12-31
6,981,000 GBP2023-12-31
Property, Plant & Equipment
0 GBP2024-12-31
0 GBP2023-12-31
Fixed Assets - Investments
0 GBP2024-12-31
0 GBP2023-12-31
Fixed Assets
0 GBP2024-12-31
6,981,000 GBP2023-12-31
Total Inventories
0 GBP2024-12-31
0 GBP2023-12-31
Debtors
7,012 GBP2024-12-31
4,474 GBP2023-12-31
Cash at bank and in hand
0 GBP2024-12-31
5,567 GBP2023-12-31
Current assets - Investments
0 GBP2024-12-31
0 GBP2023-12-31
Current Assets
7,012 GBP2024-12-31
10,041 GBP2023-12-31
Creditors
Amounts falling due within one year
-597,060 GBP2024-12-31
-552,629 GBP2023-12-31
Net Current Assets/Liabilities
-590,048 GBP2024-12-31
-542,588 GBP2023-12-31
Total Assets Less Current Liabilities
-590,048 GBP2024-12-31
6,438,412 GBP2023-12-31
Creditors
Amounts falling due after one year
0 GBP2024-12-31
0 GBP2023-12-31
Net Assets/Liabilities
-590,048 GBP2024-12-31
6,438,412 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
Share premium
6,981,000 GBP2024-12-31
6,981,000 GBP2023-12-31
Revaluation reserve
0 GBP2024-12-31
0 GBP2023-12-31
Retained earnings (accumulated losses)
-7,571,049 GBP2024-12-31
-542,589 GBP2023-12-31
Equity
-590,048 GBP2024-12-31
6,438,412 GBP2023-12-31
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
0 GBP2024-12-31
6,981,000 GBP2023-12-31
Intangible assets - Disposals
0 GBP2024-01-01 ~ 2024-12-31
Intangible Assets - Accumulated Amortisation & Impairment
0 GBP2024-12-31
0 GBP2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
0 GBP2024-01-01 ~ 2024-12-31
Intangible assets - Disposals and decrease in the amortization or impairment
0 GBP2024-01-01 ~ 2024-12-31
Debtors
Amounts falling due after one year
0 GBP2024-12-31
0 GBP2023-12-31

  • IMUTEX LIMITED
    Info
    Registered number 10124988
    icon of addressLondon Bioscience Innovation Centre, 2 Royal College Street, London NW1 0NH
    PRIVATE LIMITED COMPANY incorporated on 2016-04-14 (9 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-13
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.